The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Coronary interventions

Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention

EuroIntervention 2015;11:757-764 published online ahead of print August 2014. DOI: 10.4244/EIJY14M08_02

1. Azienda Ospedaliera ed Universitaria di Perugia, Perugia, Italy; 2. Ospedale di Assisi, Assisi, Italy; 3. Ospedale A. Manzoni, Lecco, Italy; 4. Sintesi Research S.r.l., Milan, Italy; 5. Università degli studi di Padova, Padua, Italy; 6. Fondazione Poli

Aims: We tested the prognostic value of cystatin C in patients with documented coronary artery disease (CAD) who underwent percutaneous coronary artery intervention (PCI). We also tested

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Facilitated patent haemostasis after transradial catheterisation to reduce radial artery occlusion